Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Intracranial Neoplasm”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT00047320
What this trial is testing

Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors

Who this might be right for
Brain TumorCentral Nervous System TumorsChildhood Germ Cell Tumor
Children's Oncology Group 104
Testing effectiveness (Phase 2)Study completedNCT00883688
What this trial is testing

Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma

Who this might be right for
Brain CancerPediatric Cancers
M.D. Anderson Cancer Center 24
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Testing effectiveness (Phase 2)Looking for participantsNCT06776250
What this trial is testing

Study of How Safe and Effective Tarlatamab is in Brain Cancers

Who this might be right for
Astrocytic TumorOligodendroglial Tumor
University Health Network, Toronto 44
Testing effectiveness (Phase 2)Looking for participantsNCT05660408
What this trial is testing

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

Who this might be right for
Recurrent Pulmonary OsteosarcomaRecurrent High-grade Glioma
University of Florida 36
Not applicableEnded earlyNCT04462419
What this trial is testing

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Who this might be right for
Metastatic Intracranial Malignant NeoplasmRecurrent Intracranial Neoplasm
Mayo Clinic 19
Testing effectiveness (Phase 2)Study completedNCT03660761
What this trial is testing

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Who this might be right for
Efficacy and Safety
Rongjie Tao 25
Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Early research (Phase 1)Active Not RecruitingNCT03383978
What this trial is testing

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Who this might be right for
Glioblastoma
Johann Wolfgang Goethe University Hospital 42
Early research (Phase 1)Ended earlyNCT03539731
What this trial is testing

[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers

Who this might be right for
Healthy SubjectIntracranial NeoplasmGlioblastoma
Guido A. Davidzon, MD, SM 27
Testing effectiveness (Phase 2)Looking for participantsNCT07150806
What this trial is testing

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Who this might be right for
Recurrent Meningioma
Joshua Palmer 30
Testing effectiveness (Phase 2)Study completedNCT01270724
What this trial is testing

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

Who this might be right for
CNS Germ Cell Tumor
Nationwide Children's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05786924
What this trial is testing

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Who this might be right for
Non-small Cell Lung CancerHistiocytic NeoplasmHistiocytosis+29 more
Institut de Recherches Internationales Servier 554
Not applicableStudy completedNCT00777686
What this trial is testing

Measuring Non-Enhancing Glioblastoma Progression

Who this might be right for
Brain TumorGlioblastoma
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Testing effectiveness (Phase 2)Study completedNCT04044937
What this trial is testing

Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Who this might be right for
Intracranial NeoplasmLow Grade GliomaRecurrent Glioblastoma+2 more
Thomas Hope 143
Not applicableUnknownNCT04908267
What this trial is testing

How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade Gliomas

Who this might be right for
High-grade Glioma
Weiguo Zhang 100
Testing effectiveness (Phase 2)WithdrawnNCT01782976
What this trial is testing

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Load More Results